The FDA just approved the cyclobenzaprine (Tonmya, Flexeril) for fibromyalgia. We look at three risks that medication raises in psychiatry.
CME: Take the CME Post-Test for this Episode
Published On: 09/01/2025
Duration: 16 minutes, 42 seconds
Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
No transcript available.
POWERED BY BLUBRRY
